Research Article

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery

Table 3

Correlation analysis.

MMP-9TIMP-1MMP-9/TIMP-1 ratio

Disease severity scores
APACHE II−0.0990.107−0.116
SOFA−0.1490.181−0.196
Biomarkers of inflammation
WBC0.3770.0180.268
CRP−0.0470.019−0.037
PCT−0.2460.150−0.214
Biomarkers of kidney injury
Urea−0.1540.103−0.167
Creatinine−0.1870.153−0.234
Serum NGAL−0.0890.271−0.203
Urine NGAL−0.2770.197−0.338
KIM-10.0020.144−0.104
Biomarkers of liver injury
AST−0.1450.236−0.210
ALT−0.0510.148−0.097
Total bilirubin−0.2900.102−0.266
Direct bilirubin−0.2990.143−0.263
Biomarkers of coagulation
Platelets0.371−0.1030.329
INR−0.1120.153−0.127
aPTT−0.1430.1020.135
Biomarkers of metabolic disorders
Total protein0.113−0.1090.120
Glucose−0.0620.270−0.246
Lactate−0.2110.263−0.275

Kendall’s Tau-b correlation analysis. The correlation is significant at the 0.01 level (2-tailed); the correlation is significant at the 0.05 level (2-tailed). MMP-9: matrix metalloproteinase-9; TIMP-1: tissue inhibitor of matrix metalloproteinase-1; APACHE II: Acute Physiology and Chronic Health Evaluation II score; SOFA: Sequential Organ Failure Assessment score; WBC: white blood cell; CRP: C-reactive protein; PCT: procalcitonin; NGAL: neutrophil gelatinase-associated lipocalin; KIM-1: kidney injury molecule-1; AST: aspartate aminotransferase; ALT: alanine aminotransferase; INR: international normalized ratio; aPTT: activated partial thromboplastin time.